Federal Register / Vol. 83, No. 134 / Thursday, July 12, 2018 / Notices 32299 

C. Public Comments 

Public comments are particularly 

invited on: Whether this collection of 

information is necessary, whether it will 

have practical utility; whether our 

estimate of the public burden of this 

collection of information is accurate, 

and based on valid assumptions and 

methodology; ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and ways in 

which we can minimize the burden of 

the collection of information on those 

who are to respond, through the use of 

appropriate technological collection 

techniques or other forms of information 

technology. 

Dated: July 2, 2018. 

David A. Shive, 

Chief Information Officer. 

[FR Doc. 2018–14884 Filed 7–11–18; 8:45 am] 

BILLING CODE 6820–61–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH or the 

Advisory Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC, announces the following meeting 

of the Advisory Board on Radiation and 

Worker Health (ABRWH). This meeting 

is open to the public, limited only by 

the space available. The meeting space 

accommodates approximately 150 

people and the audio conference line 

has 150 ports for callers. The public is 

welcome to submit written comments in 

advance of the meeting, to the contact 

person below. Written comments 

received in advance of the meeting will 

be included in the official record of the 

meeting. The public is also welcome to 

listen to the meeting by joining the 

teleconference (information below). 

DATES: The meeting will be held on 

August 22, 2018 from 8:30 a.m. to 5:00 

p.m., EDT, and August 23, 2018, 8:30 

a.m. to 12:00 p.m., EDT. A public 

comment session will be held on August 

22, 2018 at 5:00 p.m. and conclude at 

6:00 p.m. or following the final call for 

public comment, whichever comes first. 

ADDRESSES: Hilton Providence, 21 

Atwells Avenue, Providence, RI 02903; 

Phone: (401)–831–3900, Fax: (401)–274– 

1562 and audio conference call via FTS 

Conferencing. The USA toll-free dial-in 

number is 1–866–659–0537; the pass 

code is 9933701. Web conference by 

Skype: meeting CONNECTION: https:// 

webconf.cdc.gov/zab6/yzdq02pl?sl=1. 

FOR FURTHER INFORMATION CONTACT: 

Theodore Katz, MPA, Designated 

Federal Officer, NIOSH, CDC, 1600 

Clifton Road, Mailstop E–20, Atlanta, 

Georgia 30333, Telephone (513) 533– 

6800, Toll Free 1 (800) CDC–INFO, 

Email ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines 

which have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule, advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule, advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to the CDC. NIOSH 

implements this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

rechartered under Executive Order 

13811 on February 12, 2018, and will 

terminate on September 30, 2019. 

Purpose: This Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary 

on whether there is a class of employees 

at any Department of Energy facility 

who were exposed to radiation but for 

whom it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. 

Matters to be Considered: The agenda 

will include discussions on the 

following: NIOSH Program Update; 

Department of Labor Program Update; 

Department of Energy Program Update; 

SEC Petitions Update; possible 

discussion of a site profile review (dose 

reconstruction methods for Feed 

Materials Production Center (Fernald, 

Ohio); SEC Petitions for: Sandia 

National Laboratory (Albuquerque, New 

Mexico), Metals and Controls 

Corporation (Attleboro, Massachusetts, 

Idaho National Laboratory (Scoville, 

Idaho), and DeSoto Facility (Los 

Angeles, California); continued review 

of dose reconstruction methods 

associated with estimating skin doses; 

and a Board Work Session. Agenda 

items are subject to change as priorities 

dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri A. Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–14929 Filed 7–11–18; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee (HICPAC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Healthcare Infection Control 

Practices Advisory Committee 

(HICPAC). This meeting is open to the 

public, limited only by audio phone 

lines available. The public is also 

welcome to listen to the meeting by 

dialing 888–790–3409, passcode: 

3250534. A total of 200 lines will be 

available. To register for this call, please 

go to www.cdc.gov/hicpac. 

DATES: The meeting will be held on 

August 29, 2018, 3:00 p.m. to 5:00 p.m., 

EDT. 


amozie on DSK3GDR082PROD with NOTICES1
32300 Federal Register / Vol. 83, No. 134 / Thursday, July 12, 2018 / Notices 

ADDRESSES: Teleconference Number: 1– 

888–790–3409, passcode: 3250534. 

FOR FURTHER INFORMATION CONTACT: Erin 

Stone, M.A., HICPAC, Division of 

Healthcare Quality Promotion, NCEZID, 

CDC, 1600 Clifton Road NE, Mailstop 

A–31, Atlanta, Georgia 30333; 

Telephone (404) 639–4045, Email: 

HICPAC@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Director, Division of Healthcare 

Quality Promotion (DHQP), the Director, 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

the Director, CDC, the Secretary, Health 

and Human Services regarding (1) the 

practice of healthcare infection 

prevention and control; (2) strategies for 

surveillance, prevention, and control of 

infections, antimicrobial resistance, and 

related events in settings where 

healthcare is provided; and (3) periodic 

updating of CDC guidelines and other 

policy statements regarding prevention 

of healthcare-associated infections and 

healthcare-related conditions. 

Matters to be Considered: The agenda 

will include discussions on updates 

from the guidelines for infection 

prevention in healthcare personnel 

workgroup and the guidelines for 

infection prevention in patients of 

neonatal intensive care units 

workgroup. Agenda items are subject to 

change as priorities dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri A. Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–14930 Filed 7–11–18; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

Notice of Hearing: Reconsideration of 

Disapproval Washington Medicaid 

State Plan Amendment (SPA) 17–0027 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of hearing: 

Reconsideration of disapproval. 

SUMMARY: This notice announces an 

administrative hearing to be held on 

August 9, 2018, at the Department of 

Health and Human Services, Centers for 

Medicare & Medicaid Services, Division 

of Medicaid & Children’s Health, Seattle 

Regional Office, 701 Fifth Avenue, Suite 

1600, Seattle, WA 98104 to reconsider 

CMS’ decision to disapprove 

Washington’s Medicaid SPA 17–0027. 

DATES: Closing Date: Requests to 

participate in the hearing as a party 

must be received by the presiding 

officer by July 27, 2018. 

FOR FURTHER INFORMATION CONTACT: 

Benjamin R. Cohen, Presiding Officer, 

CMS, 2520 Lord Baltimore Drive, Suite 

L, Baltimore, Maryland 21244, 

Telephone: (410) 786–3169. 

SUPPLEMENTARY INFORMATION: This 

notice announces an administrative 

hearing to reconsider CMS’ decision to 

disapprove Washington’s Medicaid state 

plan amendment (SPA) 17–0027, which 

was submitted to the Centers for 

Medicare & Medicaid Services (CMS) on 

August 22, 2017 and disapproved on 

May 14, 2018. This SPA requested CMS 

approval to add coverage and 

reimbursement of services provided by 

Dental Health Aide Therapists (DHATs) 

under the Other Licensed Practitioner 

(OLP) benefit. Specifically, SPA 17– 

0027 proposed the coverage and 

reimbursement of services provided by 

DHATs only when furnished in a 

practice setting within the boundaries of 

a tribal reservation and only when 

operated by an Indian health program, 

and proposed to make coverage of 

DHAT services available only to 

members of a federally recognized tribe 

or those otherwise eligible for services 

under Indian Health Service criteria. 

Washington would, therefore, not 

permit Medicaid beneficiaries to receive 

Medicaid coverage for DHAT services if 

they are not members of a federally 

recognized tribe or otherwise eligible for 

services under Indian Health Service 

criteria. 

The issues to be considered at the 

hearing are whether Washington SPA 

17–0027 is inconsistent with the 

requirements of: 

• Section 1902(a)(23) of the Social 

Security Act (the Act) because it would 

restrict access to services provided by a 

DHAT to a limited group of 

beneficiaries, and it would also prevent 

beneficiaries from receiving DHAT 

services from similarly qualified dental 

services providers that provide services 

outside the boundaries of a tribal 

reservation or that are not Indian health 

programs. 

• Section 1902(a)(10)(A) of the Act 

because it was unclear whether DHATs 

must be supervised by a licensed 

professional consistent with the 

requirements of the OLP benefit, and 

because CMS was therefore unable to 

determine whether DHAT services are 

‘‘medical assistance’’ consistent with 

1902(a)(10)(A) and 1905 of the Act. 

Section 1116 of the Act and federal 

regulations at 42 CFR part 430 establish 

Department procedures that provide an 

administrative hearing for 

reconsideration of a disapproval of a 

state plan or plan amendment. CMS is 

required to publish in the Federal 

Register a copy of the notice to a state 

Medicaid agency that informs the 

agency of the time and place of the 

hearing, and the issues to be considered. 

If we subsequently notify the state 

Medicaid agency of additional issues 

that will be considered at the hearing, 

we will also publish that notice in the 

Federal Register. 

Any individual or group that wants to 

participate in the hearing as a party 

must petition the presiding officer 

within 15 days after publication of this 

notice, in accordance with the 

requirements contained at 42 CFR 

430.76(b)(2). Any interested person or 

organization that wants to participate as 

amicus curiae must petition the 

presiding officer before the hearing 

begins in accordance with the 

requirements contained at 42 CFR 

430.76(c). If the hearing is later 

rescheduled, the presiding officer will 

notify all participants. 

The notice to Washington announcing 

an administrative hearing to reconsider 

the disapproval of its SPA reads as 

follows: 

Ms. MaryAnne Lindeblad 

Director 

State of Washington, Health Care Authority 

626 8th Avenue PO Box 45502 

Olympia, WA 98504–5050 

Dear Ms. Lindeblad: 

I am responding to your June 8, 2018 

request for reconsideration of the decision to 

disapprove Washington’s State Plan 

amendment (SPA) 17–0027. Washington SPA 

17–0027 was submitted to the Centers for 

Medicare & Medicaid Services (CMS) on 

August 22, 2017, and disapproved on May 

14, 2018. I am scheduling a hearing on your 

request for reconsideration to be held on 

August 9, 2018, at the Department of Health 

and Human Services, Centers for Medicare & 

Medicaid Services, Division of Medicaid & 

Children’s Health, Seattle Regional Office, 

701 Fifth Avenue, Suite 1600, Seattle, WA 

98104. 

I am designating Mr. Benjamin R. Cohen as 

the presiding officer. If these arrangements 

present any problems, please contact Mr. 

Cohen at (410) 786–3169. In order to 

facilitate any communication that may be 

necessary between the parties prior to the 

hearing, please notify the presiding officer to 


amozie on DSK3GDR082PROD with NOTICES1